H.R. 2592 House Transportation and Public Works
Aviation Medication Transparency Act of 2025
Committee Consideration, still liveSTAGE 2 OF 8 — COMMITTEE CONSIDERATION
Currently in the House. Last action: ordered to be reported (amended) by voice vote on Sep 15, 2026.
- House Introduced in House Apr 2, 2025
- House Referred to the House Committee on Transportation and Infrastructure. Apr 2, 2025
- House Referred to the Subcommittee on Aviation. Apr 3, 2025
- House Subcommittee on Aviation Discharged Sep 15, 2026
- House Committee Consideration and Mark-up Session Held Sep 15, 2026
- House Ordered to be Reported (Amended) by Voice Vote. Sep 15, 2026
Cosponsors
25
Subjects
Aviation and airportsGovernment information and archivesLicensing and registrationsPrescription drugsTransportation employees
Committees
- Transportation and Infrastructure Committee
- [Markup By, Sep 15, 2026]
- [Referred To, Apr 2, 2025]
Summary
Aviation Medication Transparency Act of 2025This bill directs the Federal Aviation Administration (FAA) to compile, publish, and annually update a list of medications that may be safely prescribed to pilots and air traffic controllers for the purposes of issuing a medical certification. The list must be publicly available on the FAA website and distributed to those seeking a license and medical certification. Currently, the FAA does not have a list of approved medications. However, the FAA does have lists for Aviation Medical Examiners of Do Not Issue medications and Do Not Fly medications.
[Summary as of: Introduced in House]
Comments · 0
Please log in to post a comment.
Loading comments...